Financials
Financial year 2025
MANAGEMENT CONSULTING PHARMA from Perwez, company number BE1010773751, closed financial year 2025 with a result of € 101,238 after tax. For that financial year MANAGEMENT CONSULTING PHARMA recorded a gross margin of € 130,455 and equity of € 105,238. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 4, 2025.
€ 105,238
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 101,238
Profit after tax over the fiscal year.
€ 84,308
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 101,238.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 816
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,062
Supplier invoices still open on the last day of the fiscal year.
€ 48,409
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Ask about MANAGEMENT CONSULTING PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MANAGEMENT CONSULTING PHARMA?
What happened at MANAGEMENT CONSULTING PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 101,238. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Perwez. KBO
In short
Paid € 27,370 in corporate taxes since 2025.
Management
Behind MANAGEMENT CONSULTING PHARMA is Gilles DE SCHEPPER.
Directors
According to the 2025 annual accounts
Gilles DE SCHEPPER
Director
Establishments
Establishment units
Physical locations of this company
Rue de Seumay 48
1360 Perwez
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Walloon Brabant
Same main activity (Detailhandel in farmaceutische producten), 146 active companies in Walloon Brabant, largest first.
€ 172.2 million revenue · 2026 · Wavre
€ 52.2 million revenue · 2025 · Wavre
€ 50.1 million revenue · 2025 · Ottignies-Louvain-la-Neuve
€ 28.6 million revenue · 2026 · Wavre
€ 24 million revenue · 2025 · Nivelles
€ 9.5 million revenue · 2026 · Wavre
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DE SCHEPPER Gilles(oprichter) 100%
Details
- Company number
- 1010.773.751
- VAT number
- BE 1010.773.751
- Registered office
- Rue de Seumay 48, 1360 Perwez
- Names & denominations
- MANAGEMENT CONSULTING PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 June 2024
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering